Drug details
Dovato (dolutegravir and lamivudine tablets)
type of HIV, ART Combos
Dovato (dolutegravir and lamivudine) is a combination of an integrase strand transfer inhibitor (INSTI) and a nucleoside analogue reverse transcriptase inhibitor (NRTI) indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of Dovato.
The drug is often used to treat HIV .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- upper stomach pain,
- loss of appetite,
- dark urine,
- vomiting,
- diarrhea,
- fever,
- swollen glands,
- night sweats,
- weight loss,
- tiredness,
- stomach pain,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- dizziness,
- wheezing,
- weakness,
- cough,
- menstrual changes, and
- feeling cold,
- trouble speaking,
- skin rash (no matter how mild),
- difficulty swallowing,
- general ill feeling,
- fast or irregular heart rate,
- cold sores,
- problems with balance or eye movement,
- swelling in your neck or throat (enlarged thyroid),
- impotence
- joint or muscle pain,
- blisters or mouth sores,
- redness or swelling in your eyes,
- blistering or peeling skin,
- unusual muscle pain,
- prickly feeling,
The following drugs are related to Dovato, either as a replacement or used together:
- Ziagen (abacavir sulfate)
- Epzicom (abacavir sulfate and lamivudine tablets)
- Trizivir (abacavir sulfate, lamivudine, and zidovudine)
- Triumeq (abacavir, dolutegravir, and lamivudine film-coated tablets)
- Apretude (cabotegravir extended-release injectable suspension)
- Evotaz (atazanavir and cobicistat tablets for oral administration)
- Reyataz (atazanavir sulfate)
- Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
- Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide tablets)
- Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)
- Vocabria (cabotegravir tablets for oral use)
- Crixivan (indinavir sulfate)
- Prezista (darunavir)
- Prezcobix (darunavir and cobicistat tablets)
- Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir  alafenamide tablets)
- Rescriptor (delavirdine mesylate)
- Delstrigo (doravirine, lamivudine, and tenofovir disoproxil fumarate tablets)
- Videx EC (didanosine delayed-release capsules)
- Videx (didanosine pediatric powder for oral solution)
- Juluca (dolutegravir and rilpivirine tablets, for oral use)
- Pifeltro (doravirine tablets)
- Tivicay (doutegravir 50mg tablets)
- Sustiva (efavirenz)
- Vitekta (elvitegravir tablets)
- Trogarzo (ibalizumab-uiyk injection)
- Kaletra Capsules (lopinavir, ritonavir capsules)
- Kaletra Tablets (lopinavir, ritonavir tablets)
- Vemlidy Tablets (tenofovir alafenamide)